Cargando…
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients
Coronavirus disease of 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), may be complicated by life-threatening interstitial pneumonia. SARS-CoV-2 infection may also damage several tissues and/or organs beyond the lungs, including the liver. However, controvers...
Autores principales: | Romano, Ciro, Cozzolino, Domenico, Nevola, Riccardo, Abitabile, Marianna, Carusone, Caterina, Cinone, Francesca, Cuomo, Giovanna, Nappo, Francesco, Sellitto, Ausilia, Umano, Giuseppina Rosaria, Adinolfi, Luigi Elio, Marrone, Aldo, Rinaldi, Luca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537641/ https://www.ncbi.nlm.nih.gov/pubmed/37766310 http://dx.doi.org/10.3390/v15091904 |
Ejemplares similares
-
Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading)
por: Romano, Ciro, et al.
Publicado: (2022) -
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring
por: Cozzolino, Domenico, et al.
Publicado: (2022) -
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome
por: Cozzolino, Domenico, et al.
Publicado: (2023) -
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment?
por: Nevola, Riccardo, et al.
Publicado: (2022) -
Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment
por: Romano, Ciro, et al.
Publicado: (2022)